Trial intelligence / Profile preview

IXIARO Booster in Pediatric Japanese Encephalitis

NCT01296360Phase 3Completed

Sponsor
Valneva
Start
Dec 2010
Primary completion
Nov 2011
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of Japanese encephalitis inactivated vaccine in Japanese encephalitis (JE), sponsored by Valneva. Started Dec 2010; status: completed.

02

Drugs

Japanese encephalitis inactivated vaccine
03

Conditions

Japanese encephalitis (JE)

Beyond the preview

Go deeper on NCT01296360.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01296360.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call